November 25, 2008 |
Genentech Inc. and Roche Holding's Avastin, in combination with the most commonly used chemotherapies, helped women with breast cancer live longer without their disease worsening, a finding that could bolster use of the medicine. Avastin, used as a first-line therapy and combined with either Switzerland-based Roche's Xeloda, a taxane drug such as paclitaxel or anthracycline, kept tumors in check in women with advanced breast cancer better than chemotherapy alone, the companies said.
CALIFORNIA | LOCAL
December 23, 1991 |
Taxol, a drug made from the bark of the Pacific yew tree, was found to halt or slow progression of tumors in more than half of 25 breast cancer patients enrolled in clinical trials at a Houston hospital. The study, led by Dr. Frankie Ann Holmes of the University of Texas M.D. Anderson Cancer Center, found that three of 25 patients experienced complete remission of their cancer after treatment with taxol.
October 17, 2001 |
Federal regulators approved a medical device that uses a needle to freeze and destroy benign breast tumors, the Irvine company that developed the procedure said late Tuesday. With Food and Drug Administration clearance, Endocare Inc. and one of its partners can start marketing the minimally invasive "cryoablation" technology for treatment of benign tumors.
August 8, 1997 |
Researchers have found a second gene for tuberous sclerosis, a rare genetic condition that causes tumors all over the body. About 1 of every 6,000 babies is born with the condition, which can lead to epilepsy, learning difficulties, autism and kidney and skin disease. Reporting today in the journal Science, a team of European and U.S. researchers said the discovery of the second gene could lead to a test for the disorder.
May 7, 2003 |
Scientists have genetically altered a common cold virus to destroy the most lethal type of brain tumor while not harming healthy tissue nearby. Researchers hope to begin studying it in people with the tumor, glioblastoma, next year. Tumors were implanted in the brains of mice and then injected with the altered virus. Untreated mice died in 19 days, but 60% of the treated mice were alive after four months. The research is reported in the Journal of the National Cancer Institute.
January 22, 2004 |
A team of Romanian and U.S. doctors said they had removed a tumor weighing 175 pounds from a female patient in a 10-hour operation. Lucica Bunghez, 47, had been largely confined to bed because of the tumor, which weighed almost double the rest of her body and covered her back, waist and hips, doctors said. "She is very well. The lack of the tumor really suits her," said Ion Lascar, head of the plastic surgery department of Floreasca Hospital in Bucharest.
CALIFORNIA | LOCAL
October 15, 1993 |
An experimental technology that uses a pencil-like wand and a computer screen to guide doctors through brain surgery premiered in Orange County this week. Doctors used the "Viewing Wand" to locate tumors in the brains of two patients. "It went perfect," said James Doty, the neurosurgeon who led the team that performed the first two operations at Hoag Hospital.
September 21, 1987 |
Joe Cunningham had just turned 38 when his doctor told him in early 1985 that he had only 10 months to live. The Detroit tax attorney had a lymphoma deep in the brain behind his right ear. It was inoperable, and radiation is not very effective against such tumors. A third alternative was chemotherapy, but that is rarely attempted because brain tumors are shielded by a mysterious phenomenon known as the blood-brain barrier.
CALIFORNIA | LOCAL
February 9, 2000
Doctors at Childrens Hospital unveiled new radiation technology Tuesday that they say will greatly enhance their ability to fight tumors. The recently acquired Millennium 120-Leaf Collimator is the latest high-precision device for zapping tumor cells with radiation. Because it is linked to cutting-edge computer software, doctors at Childrens Hospital say it could reduce treatment time by a third and yield higher cure rates. "Much like an artist sculpts clay," said Dr.
September 28, 1989 |
The controversial abortion pill RU 486, which is sold in France and China but not the United States, may prove effective in treating a rare tumor of the brain and spinal cord, according to preliminary findings to be made public today. The results, to be presented by USC researchers at a meeting of neurological surgeons in Tucson, raise the possibility that the drug could eventually be approved for U.S. use, not to terminate pregnancies but to control tumor growth.